Trial intelligence / Profile preview

Discontinuation of Antiplatelet Therapy After Drug-Coated Balloon Treatment

NCT07398001Not yet recruiting

Sponsor
Ulsan University Hospital
Start
Feb 2026
Primary completion
Feb 2028
Countries
1
01

Overview

Randomised trial in coronary artery disease (CAD) (2 arms), sponsored by Ulsan University Hospital. Primary endpoint: Net adverse clinical events at 12 months. Planned start Feb 2026; status: not yet recruiting.

02

Conditions

coronary artery disease (CAD)

Beyond the preview

Go deeper on NCT07398001.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07398001.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call